We only have this paper's title and publication details.
Read it at the sourceMTX-PG concentrations are a useful biomarker in MTX therapy, in terms of efficacy and safety.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2017) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: